Aurinia Pharmaceuticals Inc (STU:IKAP) Stock News, Headlines & Updates
Aurinia Pharmaceuticals Inc Stock News from GuruFocus
- 1
Jun 14, 2024
Aurinia Announces 2024 Annual General Meeting Results
Business Wire • 12:00pm
Jun 05, 2024
Aurinia Presents Safety and Efficacy Profile of LUPKYNIS® for People with Lupus Nephritis at European Alliance of Associations for Rheumatology (EULAR) Congress 2024
Business Wire • 6:00am
Jun 04, 2024
Aurinia Addresses Dubious Proposals Put Forth by Lucien Selce
Business Wire • 5:00pm
Jun 03, 2024
Aurinia Provides Update on Proxy Statement
Business Wire • 6:00pm
May 30, 2024
Aurinia Will Attend 2024 Jefferies Global Healthcare Conference
Business Wire • 6:00am
May 14, 2024
Analysis Showing LUPKYNIS® is a Cost-Effective Treatment for Lupus Nephritis Presented at National Kidney Foundation's Spring Clinical Meeting 2024
Business Wire • 6:00am
May 09, 2024
Aurinia Presents Data Reinforcing LUPKYNIS® Safety and Efficacy for People with Lupus Nephritis at Congress of Clinical Rheumatology East 2024
Business Wire • 6:00am
May 07, 2024
Aurinia Will Attend 2024 RBC Capital Markets Global Healthcare Conference
Business Wire • 6:00am
May 03, 2024
Q1 2024 Aurinia Pharmaceuticals Inc Earnings Call Transcript
GuruFocus Research • 11:13pm
May 01, 2024
Aurinia Underscores Enduring Commitment to People Living with Lupus Nephritis Through Innovative Advocacy and Education Initiatives for Lupus Awareness Month
Business Wire • 6:00am
Apr 30, 2024
The U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include Long-Term Data from the AURORA Clinical Program
Business Wire • 6:00am
Apr 16, 2024
UPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Business Wire • 10:00am
Apr 15, 2024
Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024
Business Wire • 6:00am
Apr 09, 2024
Aurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor Conference
Business Wire • 6:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news